|
Fig. 1. Ectopic neurogenesis and neural plate expansion in
embryonic ectoderm injected with geminin in one bilateral half
(oriented to the right). In situ hybridization detects cells expressing
N-tubulin (aqua in A-E, H; purple in F, G) and cells expressing
injected geminin (dark pink in A-E; H) either from an expression
plasmid (A, H) or from 15 pg injected full-length (F, G) or 250 pg
Ngem (B-E) RNAs. Endogenous geminin RNA is not visible.
|
|
Fig. 2. Geminin suppresses epidermal and expands neural gene
expression. (A) Synaptobrevin (Knecht et al., 1995; Richter et al.,
1988) expression in the olfactory placode is expanded on the
geminin-injected side of the embryo (15 pg full-length RNA
injected). (B,C) otx 2 expression on geminin-injected (B) or
uninjected (C) sides of the same embryo. In B, otx 2 expression is
expanded posteriorly and the otic vesicle and branchial arches fail to
form normally. (D-F) In situ hybridization for twist (aqua) and
injected geminin (pink). Injection of 250 pg of Ngem RNA
eliminates twist staining (D,E), whereas injection of 25 pg of Ngem
expands twist expression on the injected (right) side relative to the
control half (F). (G-I) Animal hemisphere views of late gastrulae
stained to detect epidermal keratin (aqua) and either 250 pg injected
Ngem (G,H, pink stain) or 250 pg injected GFP (I, pink stain). In G
and H, epidermal keratin staining is lost in injected cells; in I,
overlap of GFP and keratin produces a dark purple stain.
|
|
Fig. 3. Structure, intracellular localization and developmental profile of geminin expression in embryos. (A) Protein sequences of geminin. The
N-terminal domain sufficient for neuralization is overscored in red and the C-terminal coiled-coil domain is overscored in blue. Accession
numbers for geminin are AF068781 (gem L), AF067856 (gem H), AF068780 (mouse gem), and AF067855 (human gem). (B,C) Animal pole
(B) and side (C) views of a blastula embryo immunostained with a geminin antibody. Most endogenous geminin is localized to the nucleus.
(D) RT-PCR analysis of geminin RNA levels in the embryo during development. Between stage 10 and 10.25, embryos were analyzed whole
(W) or subdivided into dorsal (D) or ventral (V) halves. New (zygotic) transcription of geminin is evident at stage 9 and in the dorsal half of the
embryo at stage 10.
|
|
Fig. 4. Spatial distribution of geminin transcripts in the early embryo identified by in
situ hybridization. (A,B,E,G,I-K) Geminin staining is purple in singly stained embryos.
(C,D,F,H) Geminin expression is pink in doubly stained embryos. The expression
patterns stained in aqua are brachyury (C,D), BMP4 (F), or X-Delta-1 (H).
(L) Geminin expression detected in a section of an e15 mouse embryo. Dorsal is
oriented to the right (B-D), top (E,F) or facing out (G,H). Xenopus embryos are stages
4 (A), 10 (B), 10.25 (C, D), 12 (F), 12.5 (E), 13.5 (G), 20 (H), 28 (I) and 38 (J,K).
|
|
Fig. 5. Geminin inhibits expression of the epidermalizing growth
factor BMP4 in ventral and lateral ectoderm during gastrulation.
BMP4 expression (in aqua) occurs in lateral and ventral ectoderm of
uninjected embryos (A) but is eliminated by injection of 250 pg
Ngem RNA (pink staining B,C). A and B are lateral views; C is an
animal hemisphere view; embryos are stage 12 and dorsal is to the
right. (D) BMP4 expression is downregulated in ectoderm injected
with Ngem RNA. Expression of endogenous geminin is induced by
injected Ngem (primers recognize the 3¢ untranslated region not
included in the injected RNA). Muscle actin is not induced by
geminin.
|
|
Fig. 6. BMP4 can relieve gemininâs suppression of epidermal
development. (A-F) Double in situ hybridizations with epidermal
keratin (aqua) and geminin (pink) probes at stages 10- (A), 10+ (B,
C), 12.5 (D) or 12 (E, F). A and C are dorsal views (arrowheads
mark the dorsal lip); B, E and F are animal hemisphere views.
(E) Coinjection of BMP4 and geminin; dark-purple tissue expresses
both epidermal keratin and injected geminin. (F) Coinjection of
geminin and GFP. Epidermal keratin expression is suppressed in
regions expressing injected geminin.
|
|
Fig. 7. Geminin is induced by organizer signals and activates neural
gene expression in isolated ectoderm. (A) Geminin expression in
response to inducing molecules, (B) induction of neural gene
expression by geminin, (C-F) immunostaining for N-CAM in animal
caps injected with pUASgem (C), uninjected animal caps (D) or
embryos injected in one bilateral half with pUASgem (E,F).
|
|
Fig. 8. A dominant negative geminin induces epidermis and
suppresses neural development in dorsal cells. (A-D) In situ
hybridization to detect epidermal keratin (pink) and injected geminin
(aqua; endogenous not visible); overlap produces a dark blue-purple
stain. Embryos are stage 12. (A,B) Dorsal views of embryos injected
with the geminin C-terminal domain expression plasmid (pCdim).
(C,D) Embryos injected with a plasmid encoding both Cdim and fulllength
geminin (pCdim-gem; 100 pg) and with a plasmid encoding
full-length geminin (pCMVgem; 100 pg). A remaining keratinexpressing
dorsal cell is indicated by an arrowhead. (E,F) In situ
hybridization to detect N-tubulin (dark blue in F) and ectopically
expressed geminin (pink) in transgenic embryos expressing either
pCdim (E) or pCdim-gem (F). Embryos in E, F are stage 23/24.
|